IBDEI0KQ ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,9327,1,3,0)
;;=3^Defects in Complement System
;;^UTILITY(U,$J,358.3,9327,1,4,0)
;;=4^D84.1
;;^UTILITY(U,$J,358.3,9327,2)
;;=^5002439
;;^UTILITY(U,$J,358.3,9328,0)
;;=D81.810^^39^411^5
;;^UTILITY(U,$J,358.3,9328,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9328,1,3,0)
;;=3^Biotinidase Deficiency
;;^UTILITY(U,$J,358.3,9328,1,4,0)
;;=4^D81.810
;;^UTILITY(U,$J,358.3,9328,2)
;;=^5002422
;;^UTILITY(U,$J,358.3,9329,0)
;;=E88.01^^39^411^2
;;^UTILITY(U,$J,358.3,9329,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9329,1,3,0)
;;=3^Apha-1 Antitrypsin Deficiency
;;^UTILITY(U,$J,358.3,9329,1,4,0)
;;=4^E88.01
;;^UTILITY(U,$J,358.3,9329,2)
;;=^331442
;;^UTILITY(U,$J,358.3,9330,0)
;;=J09.X1^^39^411^25
;;^UTILITY(U,$J,358.3,9330,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9330,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
;;^UTILITY(U,$J,358.3,9330,1,4,0)
;;=4^J09.X1
;;^UTILITY(U,$J,358.3,9330,2)
;;=^5008144
;;^UTILITY(U,$J,358.3,9331,0)
;;=J09.X2^^39^411^26
;;^UTILITY(U,$J,358.3,9331,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9331,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
;;^UTILITY(U,$J,358.3,9331,1,4,0)
;;=4^J09.X2
;;^UTILITY(U,$J,358.3,9331,2)
;;=^5008145
;;^UTILITY(U,$J,358.3,9332,0)
;;=J09.X3^^39^411^27
;;^UTILITY(U,$J,358.3,9332,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9332,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
;;^UTILITY(U,$J,358.3,9332,1,4,0)
;;=4^J09.X3
;;^UTILITY(U,$J,358.3,9332,2)
;;=^5008146
;;^UTILITY(U,$J,358.3,9333,0)
;;=J09.X9^^39^411^28
;;^UTILITY(U,$J,358.3,9333,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9333,1,3,0)
;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
;;^UTILITY(U,$J,358.3,9333,1,4,0)
;;=4^J09.X9
;;^UTILITY(U,$J,358.3,9333,2)
;;=^5008147
;;^UTILITY(U,$J,358.3,9334,0)
;;=J44.9^^39^411^14
;;^UTILITY(U,$J,358.3,9334,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9334,1,3,0)
;;=3^COPD,Unspec
;;^UTILITY(U,$J,358.3,9334,1,4,0)
;;=4^J44.9
;;^UTILITY(U,$J,358.3,9334,2)
;;=^5008241
;;^UTILITY(U,$J,358.3,9335,0)
;;=J44.1^^39^411^13
;;^UTILITY(U,$J,358.3,9335,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9335,1,3,0)
;;=3^COPD w/ Acute Exacerbation
;;^UTILITY(U,$J,358.3,9335,1,4,0)
;;=4^J44.1
;;^UTILITY(U,$J,358.3,9335,2)
;;=^5008240
;;^UTILITY(U,$J,358.3,9336,0)
;;=J42.^^39^411^10
;;^UTILITY(U,$J,358.3,9336,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9336,1,3,0)
;;=3^Bronchitis,Unspec Chronic
;;^UTILITY(U,$J,358.3,9336,1,4,0)
;;=4^J42.
;;^UTILITY(U,$J,358.3,9336,2)
;;=^5008234
;;^UTILITY(U,$J,358.3,9337,0)
;;=J43.9^^39^411^22
;;^UTILITY(U,$J,358.3,9337,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9337,1,3,0)
;;=3^Emphysema,Unspec
;;^UTILITY(U,$J,358.3,9337,1,4,0)
;;=4^J43.9
;;^UTILITY(U,$J,358.3,9337,2)
;;=^5008238
;;^UTILITY(U,$J,358.3,9338,0)
;;=J43.0^^39^411^30
;;^UTILITY(U,$J,358.3,9338,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9338,1,3,0)
;;=3^MacLeod's Syndrome
;;^UTILITY(U,$J,358.3,9338,1,4,0)
;;=4^J43.0
;;^UTILITY(U,$J,358.3,9338,2)
;;=^5008235
;;^UTILITY(U,$J,358.3,9339,0)
;;=J43.1^^39^411^21
;;^UTILITY(U,$J,358.3,9339,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,9339,1,3,0)
;;=3^Emphysema,Panlobular
;;^UTILITY(U,$J,358.3,9339,1,4,0)
;;=4^J43.1
;;^UTILITY(U,$J,358.3,9339,2)
;;=^5008236
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI0KQ 3788 printed Sep 23, 2025@19:26:34 Page 2
IBDEI0KQ ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,9327,1,3,0)
+2 ;;=3^Defects in Complement System
+3 ;;^UTILITY(U,$J,358.3,9327,1,4,0)
+4 ;;=4^D84.1
+5 ;;^UTILITY(U,$J,358.3,9327,2)
+6 ;;=^5002439
+7 ;;^UTILITY(U,$J,358.3,9328,0)
+8 ;;=D81.810^^39^411^5
+9 ;;^UTILITY(U,$J,358.3,9328,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,9328,1,3,0)
+12 ;;=3^Biotinidase Deficiency
+13 ;;^UTILITY(U,$J,358.3,9328,1,4,0)
+14 ;;=4^D81.810
+15 ;;^UTILITY(U,$J,358.3,9328,2)
+16 ;;=^5002422
+17 ;;^UTILITY(U,$J,358.3,9329,0)
+18 ;;=E88.01^^39^411^2
+19 ;;^UTILITY(U,$J,358.3,9329,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,9329,1,3,0)
+22 ;;=3^Apha-1 Antitrypsin Deficiency
+23 ;;^UTILITY(U,$J,358.3,9329,1,4,0)
+24 ;;=4^E88.01
+25 ;;^UTILITY(U,$J,358.3,9329,2)
+26 ;;=^331442
+27 ;;^UTILITY(U,$J,358.3,9330,0)
+28 ;;=J09.X1^^39^411^25
+29 ;;^UTILITY(U,$J,358.3,9330,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,9330,1,3,0)
+32 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Pneumonia
+33 ;;^UTILITY(U,$J,358.3,9330,1,4,0)
+34 ;;=4^J09.X1
+35 ;;^UTILITY(U,$J,358.3,9330,2)
+36 ;;=^5008144
+37 ;;^UTILITY(U,$J,358.3,9331,0)
+38 ;;=J09.X2^^39^411^26
+39 ;;^UTILITY(U,$J,358.3,9331,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,9331,1,3,0)
+42 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Resp Manifest
+43 ;;^UTILITY(U,$J,358.3,9331,1,4,0)
+44 ;;=4^J09.X2
+45 ;;^UTILITY(U,$J,358.3,9331,2)
+46 ;;=^5008145
+47 ;;^UTILITY(U,$J,358.3,9332,0)
+48 ;;=J09.X3^^39^411^27
+49 ;;^UTILITY(U,$J,358.3,9332,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,9332,1,3,0)
+52 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ GI Manifest
+53 ;;^UTILITY(U,$J,358.3,9332,1,4,0)
+54 ;;=4^J09.X3
+55 ;;^UTILITY(U,$J,358.3,9332,2)
+56 ;;=^5008146
+57 ;;^UTILITY(U,$J,358.3,9333,0)
+58 ;;=J09.X9^^39^411^28
+59 ;;^UTILITY(U,$J,358.3,9333,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,9333,1,3,0)
+62 ;;=3^Influenza d/t Indent Novel Influenza A Virus w/ Oth Manifest
+63 ;;^UTILITY(U,$J,358.3,9333,1,4,0)
+64 ;;=4^J09.X9
+65 ;;^UTILITY(U,$J,358.3,9333,2)
+66 ;;=^5008147
+67 ;;^UTILITY(U,$J,358.3,9334,0)
+68 ;;=J44.9^^39^411^14
+69 ;;^UTILITY(U,$J,358.3,9334,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,9334,1,3,0)
+72 ;;=3^COPD,Unspec
+73 ;;^UTILITY(U,$J,358.3,9334,1,4,0)
+74 ;;=4^J44.9
+75 ;;^UTILITY(U,$J,358.3,9334,2)
+76 ;;=^5008241
+77 ;;^UTILITY(U,$J,358.3,9335,0)
+78 ;;=J44.1^^39^411^13
+79 ;;^UTILITY(U,$J,358.3,9335,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,9335,1,3,0)
+82 ;;=3^COPD w/ Acute Exacerbation
+83 ;;^UTILITY(U,$J,358.3,9335,1,4,0)
+84 ;;=4^J44.1
+85 ;;^UTILITY(U,$J,358.3,9335,2)
+86 ;;=^5008240
+87 ;;^UTILITY(U,$J,358.3,9336,0)
+88 ;;=J42.^^39^411^10
+89 ;;^UTILITY(U,$J,358.3,9336,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,9336,1,3,0)
+92 ;;=3^Bronchitis,Unspec Chronic
+93 ;;^UTILITY(U,$J,358.3,9336,1,4,0)
+94 ;;=4^J42.
+95 ;;^UTILITY(U,$J,358.3,9336,2)
+96 ;;=^5008234
+97 ;;^UTILITY(U,$J,358.3,9337,0)
+98 ;;=J43.9^^39^411^22
+99 ;;^UTILITY(U,$J,358.3,9337,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,9337,1,3,0)
+102 ;;=3^Emphysema,Unspec
+103 ;;^UTILITY(U,$J,358.3,9337,1,4,0)
+104 ;;=4^J43.9
+105 ;;^UTILITY(U,$J,358.3,9337,2)
+106 ;;=^5008238
+107 ;;^UTILITY(U,$J,358.3,9338,0)
+108 ;;=J43.0^^39^411^30
+109 ;;^UTILITY(U,$J,358.3,9338,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,9338,1,3,0)
+112 ;;=3^MacLeod's Syndrome
+113 ;;^UTILITY(U,$J,358.3,9338,1,4,0)
+114 ;;=4^J43.0
+115 ;;^UTILITY(U,$J,358.3,9338,2)
+116 ;;=^5008235
+117 ;;^UTILITY(U,$J,358.3,9339,0)
+118 ;;=J43.1^^39^411^21
+119 ;;^UTILITY(U,$J,358.3,9339,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,9339,1,3,0)
+122 ;;=3^Emphysema,Panlobular
+123 ;;^UTILITY(U,$J,358.3,9339,1,4,0)
+124 ;;=4^J43.1
+125 ;;^UTILITY(U,$J,358.3,9339,2)
+126 ;;=^5008236
